Abstract

Medicinal plants containing potent bioactive compound effective in treating many diseases exert different pharmacological action. This study designed to evaluate the cytotoxic and thrombolytic activity of <i>Acacia rugata</i> of Mimosaceae family. The cytotoxic and thrombolytic activity was evaluated by brine-shrimp lethality bioassay and in-vitro clot lysis method. Methanol, petroleum-ether, n-hexane, chloroform and dichloromethane fraction leaves (MEL, PETFL, n-HxFL, CHFL, DCMFL), methanol and n-hexane fraction of fruits (MEF, n-HxFF) and methanol fraction of bark (MEB) were used to evaluate cytotoxicity of the plant. Each extracts showed significant cytotoxic property. The LC<sub>50</sub> values of MEL, PETFL, n-HxFL, CHFL, DCMFL, MEF, n-HxFF, MEB were observed 1.436, 0.039, 0.974, 0.626, 0.121, 0.176, 0.865, 0.081 µg/ml when compared to standard vincristine (positive control) which LC<sub>50</sub> value was 0.049 µg/ml. In thrombolytic activity evaluation 20 mg/ml, 10 mg/ml, 5 mg/ml and 2.5 mg/ml dose of MEL showed 40.52 ± 2.91, 35.09 ± 2.71, 31.96 ± 2.02 and 24.91 ± 3.05% clot lysis respectively while 0.9% NaCl solution (negative control) and standard streptokinase (positive control) exhibited 7.41 ± 1.73% and 48.91 ± 3.52% of clot lysis. It can be assumed that different solvent extracts of <i>A. rugata</i> have important cytotoxic and thrombolytic activity as compared to standard compounds.

Highlights

  • Medicinal plants, being a healthy source of life have always been considered to be the mean of recuperation for various diseases [1]

  • According to world Health Organization (WHO), 80% population of developing countries depends on traditional medicine for their primary health care [2]

  • Fruits and barks of Acacia rugata were collected from Bandarban Hill Districts, Bangladesh in April 2019

Read more

Summary

Introduction

Medicinal plants, being a healthy source of life have always been considered to be the mean of recuperation for various diseases [1]. According to world Health Organization (WHO), 80% population of developing countries depends on traditional medicine for their primary health care [2]. These secondary metabolites produced by plants can be used as templates to discover newer drugs [3]. Since plant possess significant pharmacological activity, low toxicity profile, economic flexibility play role in exploring new disease, investigation for their medicinal properties have been performed [6]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call